Drug allergy: the physician's and the patient's perspective

28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 06-10, 2009 -- Warsaw, POLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000266171501010…European Acad Allergy & Clin Immuno

Impact of asthma education on asthma control as assessed by the asthma control test

28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 06-10, 2009 -- Warsaw, POLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000266171501108…European Acad Allergy & Clin Immuno

Intranasal Corticosteroid Theraphy in Idiopathic Rhinitis: a Comparative Study with Allergic Rhinitis

American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting -- MAR 18-22, 2011 -- San Francisco, CAWOS: 000295846400777…Amer Acad Allergy Asthma & Immuno

Helicobacter pylori positivity in allergic inflammation

26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology -- JUN 09-13, 2007 -- Goteborg, SWEDENKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000246800000742…European Acad Allergology & Clin Immuno

Allergic rhinitis versus nonallergic rhinitis: is it possible to find the differences/similarities between the two pictures?

27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology -- JUN 07-11, 2008 -- Barcelona, SPAINKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000256235601617…European Acad Allergol & Clinical Immuno

Exercise induced anaphylaxis: does it occur only with food?

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 17-21, 2017 -- Helsinki, FINLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000408773103229…European Acad Allergy & Clin Immuno

Response to omalizumab in urticaria & asthma: "a life-time together?"

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 17-21, 2017 -- Helsinki, FINLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000408773103067…European Acad Allergy & Clin Immuno

Efficacy and safety of H1-antihistamines: An update

PubMed: 23173575H1-antihistamines are inverse agonists that combine with and stabilize inactive conformation of H1-receptors. Thus they interfere with actions of histamine at H1-receptors. They are widely used for treatment of allergic rhinitis, allergic conjunctivitis, urticaria, coughs, colds and insomnia. H1-antihistamines are classified as older 'first generation' and newer 'second generation'. First generation H1-antihistamines have poor receptor H1-receptor selectivity, and cross blood-brain-barrier. They have a lot of adverse events such as anti-muscarinic, anti-?-adrenergic, anti-serotonin, and sedative effects. In contrast, second generation H1-antihistamines were highly selective for the histamine H1-receptor, do not cross the blood brain barrier, and have minimal adverse events. The risks of first-generation H1-antihistamines have been clearly underestimated, particularly when purchased as nonprescribed over the counter medications by public. This review summarizes curent literature to evaluate antihistamines including their mechanism, indications and side-effects. © 2012 Bentham Science Publishers

Rationale of autologous serum skin test in acute vs chronic urticaria

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) -- MAY 26-30, 2018 -- Munich, GERMANYWOS: 000441690400036…European Acad Allergy & Clin Immuno

Evaluation of IgE test results in clinical practice

Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 11-15, 2016 -- Vienna, AUSTRIAKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000383679802203…European Acad Allergy & Clin Immuno